Sentences with phrase «payers as»

Signed: Your friendly former - Realtor critic - at - large with no vested interest in whether anything changes or not, but who, for the minority of real live professionals who populate the ranks of the misbegotten, feels sorry for the negative tar - brushing from the public that they receive thanks to the policies of ORE that serves the interests of «their» own back pockets whilst claiming to be there for their dues - payers as they routinely, by way of turning that blind big eye, throw them under the bus of wasted, unrealistic (supported by ORE) dreams.

Meeting one - on - one with patients to facilitate the coordination of their health information with the facility and with their insurance companies or other payers as needed.

Teenagers are also included in the list of high insurance payers as they are more likely to accidents.

The Canara Robeco Equity Tax Saver Fund is highly beneficial for tax payers as it gives them opportunity to save on income tax payments while experiencing growth through equities at the same time.

While the BBC wants the service to be available to as many licence fee payers as possible, it seems Microsoft only wants the... Read more

Doyle Teague, Director of Haywood County Animal Services, responded to the news: «We are ecstatic that the Friends of the Haywood County Animal Shelter have set this lofty goal that will ultimately reduce the burden to the county's tax payers as we outfit and purchase equipment for the proposed new facility.

To build a more growth oriented dividend portfolio we focus on three core types of dividend payers as the building blocks of our portfolios.

MG: Do you have any studies that show that dividend payers as a group outperform a broad index with less volatility, which seems to me is saying you can get more reward without taking on more risk?

Keep sticking with those solid dividend payers as you have been and long term you will have a very defensive, growing passive income stream.

I just try to balance it with some low yielding high growth div payers as well so I don't get burned at some point for chasing yield.

The levy credit functions to take local funds out of the education finance system, and returns a pittance to local property tax payers as higher needs schools are in desperate need of resources.

«By making the BBC the country's biggest mutual, with 26.8 million licence fee payers as its shareholders, we would bring greater accountability and responsiveness to secure its future in the 21st century,» Jowell said.

When trade unions sign up their levy - payers as individual members, all they're actually doing is shifting them from one category of membership to another... to a category that still has the right to select candidates that affiliated members used to have.

Labour party's national executive votes to support recruitment of union political levy payers as affiliated supporters

The manager relies on his internal payers as calls them and buys young players every window just to avoid big buys like benzema or CDM.

My guess is children from the «spiritual Marriages» are being supported by tax payers as most of the offspring from these non-legal marriages are.

I just try to balance it with some low yielding high growth div payers as well so I don't get burned at some point for chasing yield.

Tax reform could easily save tax payers as much as $ 5 billion annually.

March 28, interview with Stacy Herbert and Max Keiser on single payer as a replacement for Obamacare, here.

I tend to just prefer a dividend payer as opposed to a non-dividend payer when faced with the need to choose between a couple of (already value) stocks.

This is a form that reveals a tax credit statement showing all deductions that have been made from the income of the tax payer as well as the deductions made from deposits held if any.

Such an amount may be availed for as many as two children of an individual tax payer as a result of individual tax payers become eligible for tax deductions amounting to 200 INR in every month.

Not exact matches

Nearly two - thirds of payer executives cited cost as the biggest barrier in the way of a product overhaul.

You can use this information to adjust and take necessary actions such as searching for late payers.

As we've seen countless times over the years, tax reforms always come with unintended consequences that only emerge once tax payers have had some time to digest the new rules, adjust their reporting accordingly, and start making the tweaks and refinements that will help them maximize profit and minimize tax.

As always, blue - chip large - cap dividend payers are preferred.

Just as they have in other industries, such as shopping and banking, the way Millennials are engaging with providers and payers will likely dictate the direction younger generations are likely to head in terms of healthcare expectations.

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.

American Well, which is partnered with some of the biggest providers and payers in health care (including the Cleveland Clinic and insurance giant Anthem), is aiming to create a host of new services with Samsung and being dubbed as an end - to - end digital health «ecosystem.»

At the same time, a prospective customer may strike you as the type that may prove to be an unreliable payer.

In particular, as disclosed in filings with the U.S. Securities and Exchange Commission, Amarin's ability to effectively develop and commercialize Vascepa will depend in part on its ability to continue to effectively finance its business, efforts of third parties, its ability to create market demand for Vascepa through education, marketing and sales activities, to achieve increased market acceptance of Vascepa, to receive adequate levels of reimbursement from third - party payers, to develop and maintain a consistent source of commercial supply at a competitive price, to comply with legal and regulatory requirements in connection with the sale and promotion of Vascepa and to maintain patent protection for Vascepa.

Mylan predicated discounts to pharmacy benefits managers and government health payers like Medicaid on the condition that they would not cover EpiPen alternatives such as Auvi - Q.

Here's some of what's going on in the health care world as we head into Easter weekend: payers are pushing back against PTC Therapeutcics» controversial Duchenne muscular dystropy drug; insurers are cautiously lauding new rules for Obamacare's marketplaces; a fascinating lawsuit in Arkansas explores the ethics of drug making; and a new test for Zika virus can produce results within an hour.

That reality would seem to suggest that the U.S. should adopt a system similar to those in other countries, which more tightly regulate drug prices and where the government largely subsidizes health care costs (as opposed to employers largely doing so in the U.S.) through what's known as a single - payer system.

«As the specialty pharmacy of choice for many payers and patients, we are focused on creating the most clinically advanced specialty pharmacy experience to help improve care and outcomes for our patients,» said CVS Specialty EVP Dr. Alan Lotvin in a statement.

But drug makers say PBMs aren't transparent and don't pass savings onto consumers, which Merlo denies, adding, «That's why both public and private payers continue to count on PBMs as indispensable partners that help to manage drug trend.»

Now PTC is facing its own challenges as it figures out the proper way to price the treatment — health care payers are questioning why they should buy the treatment when the commonly available and cheap steroid prednisone is just as effective.

«[T] his is an under - estimation as all payers require prior authorization and the process is often longer than couple of weeks,» Gal wrote.

I think many of us are looking at JNJ as it's such a solid dividend payer and any chance to buy it at better prices seems very rare and short lived.

«Solid dividend payers like AWK will continue to command a premium in the market as investors are looking for any type of stable yield,» said investment instructor and small - cap stock expert Jason Bond.

However, as a dividend growth investor, I find little interest in investing my money in such hectic dividend payer.

We need, as a nation, to reexamine the single - payer plan, as many individual states are doing.

To provide a little background, I founded ikaSystems in 2000 as my third venture through which we developed an Enterprise Payer Cloud Platform that reduced administrative costs and avoidable medical costs for health insurance companies.

With over a $ 200 billion dollar backlog of orders, the company is on track to get back its status as a blue chip dividend payer.

As each market is vastly different — ranging from a complex mix of public and private health insurance to single - payer systems — entering the health technology space can seem daunting.

As such, the Company is one of the largest dividend payers in the world and has the largest share repurchase authorization in history.

What conservatives like there is that you've got, as you say, Bill, everybody's a payer.

The insurer Cigna will spend about $ 52 billion to acquire the nation's biggest pharmacy benefit manager, Express Scripts, the latest in a string of proposed tie - ups as health care's bill payers attempt to get a grip on rising costs.

Cigna will spend about $ 52 billion to acquire the nation's biggest pharmacy benefit manager, Express Scripts, the latest in a string of proposed tie - ups as health care's bill payers attempt to get a grip on rising costs.

Selected equities should not already be a top dividend payer (top 10 % of equities within the selection universe by trailing twelve month dividend yield) as they are expected to have room for further growth.